✦ LIBER ✦

Phase II clinical study of toremifene in patients with metastatic breast cancer. Preliminary communication

✍ Scribed by H. Modig; S. Borgström; I. Nilsson; G. Westman

Book ID: 116007769
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 135 KB
Volume: 36
Category: Article
ISSN: 0022-4731
DOI: 10.1016/0022-4731(90)90014-j

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of advanced breast cancer with

Treatment of advanced breast cancer with 20 mg toremifene, a phase II study. Preliminary communication

✍ S. Pyrhönen; R. Valavaara; M. Heikkinen; P. Rissanen; G. Blanco; E. Nordman; L.R 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Phase II clinical study of high-dose tor

Phase II clinical study of high-dose toremifene in patients with advanced breast cancer

✍ H. Modig; S. Borgström; I. Nilsson; G. Westman 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Effect of toremifene in breast cancer pa

Effect of toremifene in breast cancer patients. Preliminary communication

✍ I. Hindy; É. Juhos; J. Szántó; I. Számel 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Phase III studies of toremifene in metas

Phase III studies of toremifene in metastatic breast cancer

✍ Seppo O. Pyrhönen 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 441 KB

Phase II study of ionidamine in patients

Phase II study of ionidamine in patients with metastatic breast cancer

✍ H. Ian Robins; Donna S. Neuberg; Al B. Benson; Kishan J. Pandya; Douglass C. Tor 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 193 KB

The Eastern Cooperative Oncology Group conducted a phase II study of lonidamine in patients with metastatic breast cancer. The drug was given orally to a maximum daily dose of 340 mg/m 2. Forty-two patients were entered on study. One partial response was observed; there were no life-threatening toxi

Phase II clinical and pharmacological st

Phase II clinical and pharmacological study of didemnin B in patients with metastatic breast cancer

✍ John A. Benvenuto; Robert A. Newman; Gary S. Bignami; T. J. G. Raybould; Martin 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 342 KB